Rob Horne is Professor of Behavioural Medicine at the UCL School of Pharmacy, where he is Head of the Department of Practice and Policy, and Director of the Centre for Behavioural Medicine. Rob is a qualified pharmacist with a PhD in health psychology (Kings College London). He combines an initial decade in clinical pharmacy and medicines management within the NHS, with a 15 year programme of research in behavioural medicine. In 1997, he founded the Sussex NHS Research and Development Unit at the University of Brighton and was awarded a Personal Chair in Psychology in Healthcare in 2001
Rob’s research focuses on the role of psychological and behavioural factors in explaining variation in response to treatment. He has developed a range of tools and models for assessing patient perspectives’ of illness and treatment (e.g. the Beliefs about Medicines Questionnaire: BMQ and Medication Adherence Report: MARS) and frameworks for understanding treatment-related behaviours with a particular focus on adherence to medication (e.g. Necessity-Concerns Framework). This work translates into a portfolio of theory-based, pragmatic approaches to help patients get the best from treatments by supporting optimal adherence and self-management. Studies are ongoing in a range of long term conditions including HBV/HCV, asthma, COPD, diabetes, cardiovascular disease, kidney disease, HIV, inflammatory bowel disease, rheumatological disease, bipolar disorder and cancer. Recent work extends into broader aspects of health and illness such as the placebo/nocebo effect and the role of language, emotion and emotional disclosure in illness-related behaviours and outcomes.
Over the past decade, his research has generated over 140 peer-reviewed publications and book chapters, and grants over £7 million. His team regularly contribute to national and international reports and guidelines on adherence, and to consultancy for national charities, the NHS and commercial health organisations.
Rob was designated a Fellow of the Royal Pharmaceutical Society of Great Britain in 2010 and was appointed a National Institute for Health Research (NIHR) Senior Investigator in 2011.